Resources › EU Financial Regulatory Q&A Database EU Financial Regulatory Q&A Database Official Q&As published by EBA, ESMA, EIOPA and the ESA Joint Committee. Non-binding but treated
as authoritative guidance by national competent authorities across the EU.
Final — published answer Archive — superseded (EBA only) Pending — awaiting answer Rejected — out of scope or duplicate
All regulations Alternative Investment Fund Managers Directive (AIFMD) Directive 2011/61/EU Benchmarks Regulation (BMR) - Regulation 2016/1011 Central Securities Depositories Regulation (CSDR) Regulation (EU) No 909/2014- PTR- CSDR Credit Rating Agencies Regulation (CRAR) Regulation (EC) No 1060/2009 Directive 2002/87/EC (FiCOD) Directive 2009/110/EC (EMD) Directive 2013/36/EU (CRD) Directive 2014/17/EU (MCD) Directive 2014/49/EU (DGSD) Directive 2014/59/EU (BRRD) Directive 2014/65/EU - Markets in Financial Instruments Directive (MiFID II) Directive 2014/92/EU (PAD) Directive 2015/2366/EU (PSD2) Directive 2022/2556/EU (DORA Dir) Directive (EU) 2015/849 (AMLD) Directive (EU) 2019/2034 (IFD) EIOPA-BoS/18-114 - Information request towards NCAs regarding provision of occupational pensions information EIOPA-BoS-23-030 - Regular information requests regarding provision of occupational pensions information EMIR ESGR - Regulation (EU) 2024/3005 (EU) 2016/2341 - IORP II Directive (EU) 2016/2341 - IORP II Directive, (EU) No 2016/97 - Insurance Distribution Directive (EU) 2016/2341 - IORP II Directive, Other (EU) 2017/653 - PRIIPs Delegated Regulation for key information document (EU) 2017/653 - PRIIPs Delegated Regulation for key information document, (EU) No 1286/2014 - PRIIPs Regulation (EU) 2019/1238 - Pan-European Personal Pension Product (PEPP) (EU) 2019/1238 - Pan-European Personal Pension Product (PEPP), (EU) 2022/2454 - ITS with regard to supervisory reporting of risk concentrations and intra-group transactions (FICOD, (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, EIOPA-BoS-23-030 - Regular information requests regarding provision of occupational pensions information (EU) 2019/2088 - SFDR (EU) 2020/852 - Taxonomy Regulation (EU) 2022/2454 - ITS with regard to supervisory reporting of risk concentrations and intra-group transactions (FICOD (EU) 2022/2454 - ITS with regard to supervisory reporting of risk concentrations and intra-group transactions (FICOD, (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision (EU) 2022/2554 - Digital Operational Resilience Act (DORA) (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, (EU) 2023/895 - ITS for the disclosure of solvency and financial condition report (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, Other (EU) 2023/894 - ITS with regard to the templates for the submission of information necessary for supervision, Revised Guidelines on Contract Boundaries, Guidelines on contract boundaries (EU) 2023/895 - ITS for the disclosure of solvency and financial condition report EU Green Bond Regulation (EU) 2023/2361 (EU) No 1286/2014 - PRIIPs Regulation (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/2011 - lists of regional governments & local authorities, exposures to be treated as to central government (EU) No 2015/2013 - standard deviations in relation to health risk equalisation systems (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities, Guidelines on reporting and public disclosure (EU) No 2015/2451 - templates and structure of the disclosure of specific information by supervisory authorities (EU) No 2015/2451 - templates and structure of the disclosure of specific information by supervisory authorities, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/2452 - procedures, formats and templates of the solvency and financial condition report (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2015/2011 - lists of regional governments & local authorities, exposures to be treated as to central government (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2015/2450 - templates for the submission of information to the supervisory authorities, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on application of outwards reinsurance (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on contract boundaries (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on group solvency (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on implementation of the long-term guarantee measures (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on look-through approach (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on methodology for equivalence assessments by national supervisory authorities under Solvency II (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on recognition and valuation of assets and liabilities other than technical provisions (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on valuation of technical provisions (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Guidelines on valuation of technical provisions, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Other (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), Risk-Free Interest Rate - General questions (EU) No 2016/1800 - allocation of Credit Assessments of external CA institutions to objective scale of credit quality steps (EU) No 2016/97 - Insurance Distribution Directive (EU) No 2016/97 - Insurance Distribution Directive, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) (EU) No 2017/1469 - standardised presentation format for the insurance product information document (EU) No 2017/1469 - standardised presentation format for the insurance product information document, Guidelines on classification of own funds (EU) No 2017/2358 - product oversight and governance requirements for insurance (EU) No 2017/2358 - product oversight and governance requirements for insurance, (EU) No 2016/97 - Insurance Distribution Directive (EU) No 2017/2358 - product oversight and governance requirements for insurance, Preparatory Guidelines on product oversight & governance arrangements by insurance undertakings & insurance distributors, (EU) No 2016/97 - Insurance Distribution Directive (EU) No 2017/2359 - info requirements and conduct of business rules applicable European Long-Term Investment Funds Regulation (ELTIF) Regulation (EU) 2015/760 European Market Infrastructure Regulation (EMIR) Regulation (EU) No 648/2012- MDP European Market Infrastructure Regulation (EMIR) Regulation (EU) No 648/2012- PTR- Derivatives European Social Entrepreneurship Funds Regulation (EuSEF) Regulation (EU) No 346/2013 European Venture Capital Regulation (EuVECA) Regulation (EU) No 345/2013 Guidelines on application of life underwriting risk module Guidelines on application of outwards reinsurance Guidelines on basis risk Guidelines on classification of own funds Guidelines on classification of own funds, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) Guidelines on contract boundaries Guidelines on financial stability reporting Guidelines on financial stability reporting, Guidelines on reporting for financial stability purposes Guidelines on group solvency Guidelines on health catastrophe risk sub-module Guidelines on look-through approach Guidelines on loss-absorbing capacity of technical provisions and deferred taxes Guidelines on own risk and solvency assessment Guidelines on recognition and valuation of assets and liabilities other than technical provisions Guidelines on reporting and public disclosure Guidelines on reporting for financial stability purposes Guidelines on ring-fenced funds Guidelines on submission of information to NCAs (Preparatory phase) Guidelines on supervision of branches of third-country insurance undertakings Guidelines on supervisory review process Guidelines on system of governance Guidelines on the Forward looking assessment of own risks Guidelines on treatment of related undertakings, including participations Guidelines on use of internal models Guidelines on valuation of technical provisions Market Abuse Regulation (MAR) Regulation (EU) No 596/2014 - Market Intergrity Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- Investor Protection and Intermediaries Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- MDP Markets in Financial Instruments Directive II (MiFID II) Directive 2014/65/EU- Secondary Markets Markets in Financial Instruments Regulation (MiFIR) Regulation (EU) No 600/2014 - Investor Protection and Intermediaries Markets in Financial Instruments Regulation (MiFIR) Regulation (EU) No 600/2014- MDP Markets in Financial Instruments Regulation (MiFIR) Regulation (EU) No 600/2014- Secondary Markets MiCA Other Packaged Retail and Insurance-based Investment Products Regulation (PRIIPS) Regulation (EU) No 1286/2014 PRIIPs Prospectus Regulation 2017/1129 Regulation 2020/1503 - European crowdfunding service providers for business Regulation 2021/23 - recovery and resolution of central counterparties (CCPRRR) Regulation 648/2012 - OTC derivatives, central counterparties and trade repositories (EMIR) - CCPs Regulation (EU) 2015/847 (WTR) (recast) Regulation (EU) 2019/2088 - Sustainable Finance Disclosure Regulation (SFDR) Regulation (EU) 2022/2554 - The Digital Operational Resilience Act (DORA) Regulation (EU) 2022/858 - DLT Pilot Regime Regulation (DLTR) Regulation (EU) 2023/1113 (WTR II) Regulation (EU) 2024/886 (IPR) Regulation (EU) No 2017/2402 (SecReg) Regulation (EU) No 2019/2033 (IFR) Regulation (EU) No 2022/2554 (DORA Reg) Regulation (EU) No 2023/1114 (MiCAR) Regulation (EU) No 575/2013 (CRR) Regulation (EU) No 648/2012 (EMIR) Regulation (EU) No 909/2014 (CSDR) - only RTS 2017/390 Revised Guidelines on Contract Boundaries Revised Guidelines on valuation of technical provisions Revised Guidelines on valuation of technical provisions, (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) Revised Guidelines on valuation of technical provisions, (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII), (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) Risk-Free Interest Rate - Credit and currency adjustments Risk-Free Interest Rate - Deep, Liquid and Transparent maturities Risk-Free Interest Rate - Extrapolation Risk-Free Interest Rate - Extrapolation, Risk-Free Interest Rate - Financial market data Risk-Free Interest Rate - Extrapolation, Risk-Free Interest Rate - General questions, Risk-Free Interest Rate - VA calculations Risk-Free Interest Rate - Financial market data Risk-Free Interest Rate - General questions Risk-Free Interest Rate - Matching adjustment Risk-Free Interest Rate - Matching adjustment, (EU) No 2009/138 - Solvency II Directive (Insurance and Reinsurance) Risk-Free Interest Rate - VA calculations Risk-Free Interest Rate - VA calculations, Risk-Free Interest Rate - VA representative portfolios Risk-Free Interest Rate - VA representative portfolios Securities Financing Transactions Regulation (SFTR) Regulation (EU) 2015/2365- MDP Securitisation Regulation (EU) 2017/2402 SFDR Short Selling Regulation (SSR) Regulation (EU) No 236/2012 Symmetric adjustment of the equity capital charge Transparency Directive (TD) Directive 2004/109/EC Undertakings for Collective Investment in Transferable Securities Directive (UCITS) Directive 2009/65/EC
7,005 Q&As · page 39 of 141
Annex I, Table I, indicator 13 (board gender diversity). Assume a company has 5 female
board members and no male board members. The indicator is defined as follows: Average
ratio of female to male boa
SFDR
Joint Committee Final
Answered 2022-11-17
Would a discretionary mandate that invests according to Investment Guidelines
stipulated by the client be regarded as a financial product falling under Article 8 or Article
9 SFDR?
SFDR
Joint Committee Final
Answered 2022-11-17
Can taxonomy-aligned activities or PAI impacts from green bonds (or other specific
project financing instruments like social bonds) be calculated for the projects they finance
rather than taxonomy-ali
SFDR
Joint Committee Final
Answered 2022-11-17
An economic activity qualifies as environmentally sustainable where it contributes
substantially to one or more of the six environmental objectives listed under Article 9 TR.
During the period 1 Janua
SFDR
Joint Committee Final
Answered 2022-11-17
Do the rules for financial advisers also apply to financial advisers carrying non-advised
sales (execution only)?
SFDR
Joint Committee Final
Answered 2022-11-17
Example on how to calculate the value on an Indicator where an FMP has 2 Financial Products (FP) with 2 investments (Inv) each.
SFDR
Joint Committee Final
Answered 2022-11-17
Are financial market participants allowed to define their own substantial contribution
criteria for socially sustainable investments? Can a single financial market participant
apply different interpre
SFDR
Joint Committee Final
Answered 2022-11-17
Article 9(3) SFDR sets out disclosure requirements for “a financial product, [which] has a
reduction of carbon emissions as its objective”. Does this also apply if a financial product
has “reduction o
SFDR
Joint Committee Final
Answered 2022-11-17
How do you calculate indicator 8 (Emissions to water) from Table 1 (and similar indicators)
where the explicit formula is not provided?
SFDR
Joint Committee Final
Answered 2022-11-17
Can the objective-aligned index designated as a reference benchmark under Article 9(1)
SFDR, i.e. the “designated index” referred to in 9(1)(a) or 9(1)(b), be a broad market index?
SFDR
Joint Committee Final
Answered 2022-11-17
Would it be possible to have a financial product disclosing under Article 8 SFDR that
makes sustainable investments with environmental objectives which are not (yet)
taxonomy aligned?
SFDR
Joint Committee Final
Answered 2022-11-17
Is it possible to comply with Article 6 SFDR by just saying that sustainability risks are not
being integrated and not taken into account yet, or does Article 6 SFDR mean that
sustainability risks sho
SFDR
Joint Committee Final
Answered 2022-11-17
Reporting Templates
(EU) No 2015/2450 - templates for the submission of information to the supervisory authorities · Art. Article 35 of SII Directive
EIOPA
Answered 2022-11-16
Solvency Capital Requirement (SCR)
(EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) · Art. 189(3)
EIOPA
Answered 2022-11-16
Other
Guidelines on reporting and public disclosure · Art. Directive 2014/65/EU
EIOPA
Answered 2022-11-16
Own Funds (OF)
(EU) No 2017/1469 - standardised presentation format for the insurance product information document, Guidelines on classification of own funds · Art. N/A
EIOPA
Answered 2022-11-16
Persons professionally arranging or executing transactions
Market Abuse Regulation (MAR) Regulation (EU) No 596/2014 - Market Intergrity
ESMA Answer Published
Answered 2022-11-15
Settlement fails
Central Securities Depositories Regulation (CSDR) Regulation (EU) No 909/2014- PTR- CSDR
ESMA Answer Published
Answered 2022-11-15
Own Funds (OF)
(EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) · Art. Article 1 (item 46); Article 260 (item 2 and 3)
EIOPA
Answered 2022-11-15
Point 12 of Annex IV of the Delegated Regulation notes that where the objectives of the PRIIP make
reference to a benchmark, that benchmark shall be used for the performance scenario calculations.
How
PRIIPs
Joint Committee Final
Answered 2022-11-14
What is the relationship between point 11 of Annex IV and Article 15 of the Delegated Regulation?
PRIIPs
Joint Committee Final
Answered 2022-11-14
Regarding Article 8(3) of the Delegated Regulation:
a) What is meant by "performance scenario calculations"? Is it necessary for the full calculations
underlying each scenario to be published or just
PRIIPs
Joint Committee Final
Answered 2022-11-14
How should actively-managed UCITS ETF be identified in the KID, and what information should be
included in the “What is this product?” section of the KID?
An actively-managed UCITS ETF should inform i
PRIIPs
Joint Committee Final
Answered 2022-11-14
For the identification of additional shorter sub intervals in point 7(b) of Annex IV of the Delegated
Regulation, does this mean only the sub intervals that are truncated by the end of the time period
PRIIPs
Joint Committee Final
Answered 2022-11-14
Article 14(e) of the Delegated Regulation refers only to the publication of past performance of the
underlying Category 2 investment options as required by Article 8(3) and not to the requirement in
A
PRIIPs
Joint Committee Final
Answered 2022-11-14
How should UCITS ETFs be identified in the KID, and what information should be included in the
“What is this product?” section of the KID?
A UCITS ETF should use the term ‘UCITS ETF’ which identifies
PRIIPs
Joint Committee Final
Answered 2022-11-14
Should individual KIDs be prepared for each class of units or shares within a UCITS or AIF?
PRIIPs
Joint Committee Final
Answered 2022-11-14
Is it possible to alter the prescribed wording in the KID template for OTC derivatives?
It is recognised in point 6a of Annex III and point 12 of Annex V of the Delegated Regulation that some
of the s
PRIIPs
Joint Committee Final
Answered 2022-11-14
Should existing retail investors within a UCITS umbrella fund, who switch or exchange units in one
sub-fund for units in another, be provided with the KID for the sub-fund in which they are going into
PRIIPs
Joint Committee Final
Answered 2022-11-14
Point 19 of Annex VIII of the Delegated Regulation states that “In the case of mergers referred to in
Article 2(1)(p)(i) and (iii) of Directive 2009/65/EC, only the past performance of the receiving U
PRIIPs
Joint Committee Final
Answered 2022-11-14
Do the rules concerning the UCITS key investor information document (KIID) still apply?
PRIIPs
Joint Committee Final
Answered 2022-11-14
When several versions of a benchmark are available which differ in the approach taken to
reinvestment of revenues, which version should be used in the past performance chart?
PRIIPs
Joint Committee Final
Answered 2022-11-14
[Question deleted]
(Revised 21 December 2022)
3. Which form and name should the ‘specific information on each underlying investment option’,
referred to in Article 14 of the Delegated Regulation, tak
PRIIPs
Joint Committee Final
Answered 2022-11-14
Does the requirements in Articles 6(1) and 9 of the PRIIPs Regulation mean that past performance
disclosed regarding a benchmark index should be consistent with past performance disclosure in
other in
PRIIPs
Joint Committee Final
Answered 2022-11-14
What should be displayed in the bar chart for years when there is no data?
PRIIPs
Joint Committee Final
Answered 2022-11-14
For autocallables, for an early call scenario, what time periods should be used when calculating the
performance scenarios and cost figures?
PRIIPs
Joint Committee Final
Answered 2022-11-14
If a UCITS, AIF or unit-linked insurance-based investment product does not yet have past performance
data for one complete calendar year (and is not a UCITS or AIF which may provide simulated data for
PRIIPs
Joint Committee Final
Answered 2022-11-14
In terms of the identification of sub intervals in point 7(a) of Annex IV of the Delegated Regulation
are these all contained within in the time period defined in point 6 of Annex IV?
PRIIPs
Joint Committee Final
Answered 2022-11-14
Can a fund with multiple share classes use the price history of an existing share class when a new
share class is created rather than use the price history of a benchmark?
PRIIPs
Joint Committee Final
Answered 2022-11-14
Where a UCITS, AIF or unit-linked insurance-based investment product refers to an index in its
investment objectives and policy as a benchmark and will measure the performance against that
index, but
PRIIPs
Joint Committee Final
Answered 2022-11-14
What type of information should be included in the “What is this product?” section of the KID of
index-tracking UCITS and index-tracking leveraged UCITS?
For index-tracking UCITS, the following inform
PRIIPs
Joint Committee Final
Answered 2022-11-14
What is the meaning of indicating ‘the degree of freedom from the benchmark’ in Article 2a(d) of the
Delegated Regulation?
PRIIPs
Joint Committee Final
Answered 2022-11-14
Are the redemption prices of open-ended real estate AIFs "prices" within the meaning of point 5 of
Annex II of the Delegated Regulation?
PRIIPs
Joint Committee Final
Answered 2022-11-14
What is the meaning of ‘whether this approach includes or implies a reference to a benchmark’ in
Article 2a(d) of the Delegated Regulation?
A UCITS or AIF managed in reference to a benchmark index is
PRIIPs
Joint Committee Final
Answered 2022-11-14
Does Article 2(2a)(d) of the Delegated Regulation require a UCITS or AIF to provide a clear indication
of whether it is actively or passively managed?
PRIIPs
Joint Committee Final
Answered 2022-11-14
Is it required to keep the same benchmark for the SRI and performance scenario calculations?
PRIIPs
Joint Committee Final
Answered 2022-11-14
What approach should be taken for Category 2 PRIIPs for which there is not an appropriate
benchmark or proxy with sufficient historical data which meets the criteria set out in point 5 of Annex
IV of
PRIIPs
Joint Committee Final
Answered 2022-11-14
Is it possible to show the complete name of the PRIIP when first mentioned in the KID and then simply
refer to it as “the product” or “the Fund” thereafter?
PRIIPs
Joint Committee Final
Answered 2022-11-14
In the Delegated Regulation, the VEV for flexible funds is determined by taking the maximum of the
three following options: 1. VEV of the returns of the share class self-history, 2. VEV of the returns
PRIIPs
Joint Committee Final
Answered 2022-11-14
Could you clarify for which intermediate holding periods should we show performance scenarios
during the lifetime of a product? (E.g.: 1.1 years product, with remaining lifetime of 9 months). We
belie
PRIIPs
Joint Committee Final
Answered 2022-11-14
← Previous 1 37 38 39 40 41 141 Next → Source: EBA Single Rulebook Q&A , ESMA Q&A , EIOPA Q&A , ESA Joint Q&As . Updated weekly. Q&As are non-binding guidance.